SCHEMBL29636726

SCHEMBL29636726

Cn1cc(-c2cc(C(N)CCN)c3ccccc3n2)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.46
ALDH1A1 P00352 3/20 0.42
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
PKM P14618 1/20 0.42
GPR39 O43194 1/20 0.42
KDM1A O60341 1/20 0.40
MET P08581 1/20 0.40
FGFR3 P22607 3/20 0.39
KDR P35968 3/20 0.39
FGFR1 P11362 2/20 0.39
FGFR2 P21802 2/20 0.39
FGFR4 P22455 2/20 0.39
PIM1 P11309 1/20 0.39
EPHX2 P34913 1/20 0.39
ACHE P22303 1/20 0.39
ALOX5AP P20292 1/20 0.39
FEN1 P39748 1/20 0.39
MCL1 Q07820 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23015344 1.00 GRM2 (0.46) GRM2ALDH1A1MAPTKDM4ELMNA
SCHEMBL30964788 0.85 GRM2 (0.49) GRM2ALDH1A1MAPTKDM4ELMNA
SCHEMBL29636681 0.84 EGFR (0.49) METFGFR3KDRFGFR1FGFR2
SCHEMBL23015372 0.84 EGFR (0.49) METFGFR3KDRFGFR1FGFR2
SCHEMBL29636664 0.83 ACP1 (0.42) ALDH1A1MAPTKDM4ELMNAPKM
SCHEMBL23015140 0.83 ACP1 (0.42) ALDH1A1MAPTKDM4ELMNAPKM
SCHEMBL23015286 0.82 ACP1 (0.46) ALDH1A1MAPTKDM4ELMNAPKM
SCHEMBL29636661 0.82 ACP1 (0.46) ALDH1A1MAPTKDM4ELMNAPKM
SCHEMBL23015213 0.80 MET (0.48) MET
SCHEMBL29636634 0.80 MET (0.48) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4017492-A1 MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED DISORDERS Biohaven Therapeutics Ltd. (US) 2022-06-29 EP claimed
EP-4017492-A1 MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED DISORDERS Biohaven Therapeutics Ltd. (US) 2022-06-29 EP disclosed
CN-114667145-A Molecules that bind to TDP-43 for the treatment of amyotrophic lateral sclerosis and related disorders 拜尔哈文制药股份有限公司 2022-06-24 CN disclosed